Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients

Zhao‐Xu Chen, Huiqing Jia, Huina Zhang, +7

Breast Cancer Research and Treatment

Primary mucinous cystadenocarcinoma of the breast: a clinicopathologic analysis of one case and review of the literature.

Xiao Wang, Yujun Li, Peng Zhao, +4

PubMed

Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/β-Catenin Signaling

Chengqin Wang, Runze Zhang, Xiao Wang, +7

Frontiers in Oncology

Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT

Yan Zheng, Huiqing Jia, Ping Wang, +6

Cancer Gene Therapy

Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder

Guofeng Ma, Huiqing Jia, Guofang Zhang, +5

The Oncologist

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast

Huiqing Jia, Peng Zhao, Zhao‐Xu Chen, +5

Breast Cancer Research and Treatment